{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:18:21Z","timestamp":1789759101155,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clcc.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T01:21:29Z","timestamp":1520472089000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tolerability, Safety, and Outcomes of Neoadjuvant Chemoradiotherapy With Capecitabine for Patients Aged\u00a0\u2265 70 Years With Locally Advanced Rectal Cancer"],"prefix":"10.1016","volume":"17","author":[{"given":"Lotte","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"van der Vlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0606-741X","authenticated-orcid":false,"given":"Daan","family":"ten Bokkel Huinink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiko","family":"Bloemendal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5068-5517","authenticated-orcid":false,"given":"Martijn","family":"Intven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke B.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas L.A.M.","family":"Weusten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Siersema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"van Lelyveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4953-5271","authenticated-orcid":false,"given":"Maartje","family":"Los","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2018.03.004_bib1","first-page":"104","article-title":"Colorectal cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clcc.2018.03.004_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/annonc\/mdn532","article-title":"Treatment of the elderly colorectal cancer patient: SIOG expert recommendations","volume":"20","author":"Papamichael","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2018.03.004_bib3","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(09)61460-4","article-title":"Ageing populations: the challenges ahead","volume":"374","author":"Christensen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2018.03.004_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1634\/theoncologist.2007-0043","article-title":"Chemotherapy in elderly patients with colorectal cancer","volume":"13","author":"Kohne","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.clcc.2018.03.004_bib5","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM200110113451512","article-title":"Older age\u2014not a barrier to cancer treatment","volume":"345","author":"Muss","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2018.03.004_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: Globocan 2000","volume":"94","author":"Parkin","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2018.03.004_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/annonc\/mdi098","article-title":"Cancer incidence and mortality in Europe, 2004","volume":"16","author":"Boyle","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2018.03.004_bib8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2018.03.004_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/1097-0142(19900701)66:1<49::AID-CNCR2820660111>3.0.CO;2-1","article-title":"Preoperative short-term radiation therapy in operable rectal carcinoma: a prospective randomized trial","volume":"66","author":"Stockholm Rectal Cancer Study Group","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2018.03.004_bib10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF02305759","article-title":"Randomized study on preoperative radiotherapy in rectal carcinoma","volume":"3","author":"Stockholm Rectal Cancer Study Group","year":"1996","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2018.03.004_bib11","first-page":"397","article-title":"Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma","volume":"162","author":"Swedish Rectal Cancer Trial","year":"1996","journal-title":"Eur J Surg"},{"key":"10.1016\/j.clcc.2018.03.004_bib12","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(01)06409-1","article-title":"Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2018.03.004_bib13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jama.284.8.1008","article-title":"Preoperative radiotherapy for resectable rectal cancer: a meta-analysis","volume":"284","author":"Camma","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clcc.2018.03.004_bib14","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2018.03.004_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00423-006-0139-0","article-title":"Acceptance of neoadjuvant short-term radiotherapy: a survey under surgeons and radiotherapists","volume":"392","author":"Ulrich","year":"2007","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.clcc.2018.03.004_bib16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2018.03.004_bib17","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2003.08.010","article-title":"Participation of patients 65 years of age or older in cancer clinical trials","volume":"21","author":"Lewis","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2018.03.004_bib18","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"Underrepresentation of patients 65 years of age or older in cancer-treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2018.03.004_bib19","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203","volume":"24","author":"Gerard","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2018.03.004_bib20","unstructured":"National guideline coloncarcinoma. Oncoline. Available at: http:\/\/www.oncoline.nl\/colorectaalcarcinoom Accessed: October 1, 2017 ."},{"issue":"suppl 6","key":"10.1016\/j.clcc.2018.03.004_bib21","doi-asserted-by":"crossref","first-page":"vi81","DOI":"10.1093\/annonc\/mdt240","article-title":"ESMO Guidelines Working Group. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Glimelius","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2018.03.004_bib22","author":"National Cancer Institute"},{"key":"10.1016\/j.clcc.2018.03.004_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/annonc\/mdj041","article-title":"Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study","volume":"17","author":"De Paoli","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2018.03.004_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0360-3016(02)02856-0","article-title":"Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer","volume":"54","author":"Kim","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2018.03.004_bib25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ijrobp.2006.05.063","article-title":"Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer","volume":"66","author":"Krishnan","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2018.03.004_bib26","first-page":"71","article-title":"Preoperative chemoradiation with capecitabine in locally advanced rectal cancer","volume":"66","author":"de Bruin","year":"2008","journal-title":"Neth J Med"},{"key":"10.1016\/j.clcc.2018.03.004_bib27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.radonc.2013.10.019","article-title":"Results in the elderly with locally advanced rectal cancer from the ACCORD 12\/PRODIGE 2 phase III trial: tolerance and efficacy","volume":"110","author":"Francois","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2018.03.004_bib28","first-page":"165","article-title":"Systematic review of management of colorectal cancer in elderly patients","volume":"3","author":"Au","year":"2003","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clcc.2018.03.004_bib29","first-page":"362","article-title":"Toxicities and survival among octogenarians and nonagenarians with colorectal cancer treated with chemotherapy or concurrent chemoradiation therapy","volume":"6","author":"Reddy","year":"2007","journal-title":"Clin Colorectal Cancer"},{"issue":"suppl 5B","key":"10.1016\/j.clcc.2018.03.004_bib30","first-page":"3913","article-title":"Rectal cancer neoadjuvant treatment in elderly patients","volume":"26","author":"Pasetto","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clcc.2018.03.004_bib31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40266-016-0367-0","article-title":"Preoperative chemoradiotherapy for rectal cancer in patients aged 75 years and older: acute toxicity, compliance with treatment, and early results","volume":"33","author":"Guimas","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.clcc.2018.03.004_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.dld.2011.10.017","article-title":"Safety and outcome of chemoradiotherapy in elderly patients with rectal cancer: results from two French tertiary centres","volume":"44","author":"Tougeron","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clcc.2018.03.004_bib33","doi-asserted-by":"crossref","first-page":"e735","DOI":"10.1016\/j.ijrobp.2010.12.056","article-title":"Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older","volume":"81","author":"Margalit","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2018.03.004_bib34","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/030089161209800513","article-title":"Effects of preoperative radiochemotherapy with capecitabine for resectable locally advanced rectal cancer in elderly patients","volume":"98","author":"C\u00e8faro","year":"2012","journal-title":"Tumori"},{"key":"10.1016\/j.clcc.2018.03.004_bib35","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00423-010-0708-0","volume":"395","author":"Garlipp","year":"2010","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.clcc.2018.03.004_bib36","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1245\/s10434-006-9338-8","article-title":"Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy","volume":"14","author":"Valenti","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2018.03.004_bib37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/bjs.9697","article-title":"Systematic review of preoperative, intraoperative and postoperative risk factors for colorectal anastomotic leaks","volume":"102","author":"McDermott","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.clcc.2018.03.004_bib39","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.ejca.2007.07.009","article-title":"Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery","volume":"43","author":"Rutten","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2018.03.004_bib40","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2018.03.004_bib41","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/01.sla.0000225360.99257.73","article-title":"Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: impact of postirradiated pathologic downstaging on local recurrence and survival","volume":"244","author":"Kim","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2018.03.004_bib42","doi-asserted-by":"crossref","first-page":"O168","DOI":"10.1111\/codi.13060","article-title":"Time trends, improvements and national auditing of rectal cancer management over an 18-year period","volume":"17","author":"Kodeda","year":"2015","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.clcc.2018.03.004_bib43","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1111\/j.1463-1318.2009.02012.x","article-title":"Danish Colorectal Cancer Group. Improved survival after rectal cancer in Denmark","volume":"12","author":"Bulow","year":"2010","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.clcc.2018.03.004_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00384-013-1772-z","article-title":"Rectal cancer: prognostic indicators of long-term outcome in patients considered for surgery","volume":"29","author":"Bown","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.clcc.2018.03.004_bib45","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3109\/0284186X.2015.1034876","article-title":"Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010","volume":"54","author":"Guren","year":"2015","journal-title":"Acta Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002817304140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002817304140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:05:48Z","timestamp":1761519948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002817304140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1533002817304140"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2018.03.004","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tolerability, Safety, and Outcomes of Neoadjuvant Chemoradiotherapy With Capecitabine for Patients Aged\u00a0\u2265 70 Years With Locally Advanced Rectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}